This Article Full Text Full Text (PDF) All Versions of this Article: 90/4/2259    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Schaub, R. L. Articles by Cody, J. D. Search for Related Content PubMed PubMed Citation Articles by Schaub, R. L. Articles by Cody, J. D. Related Collections Thyroid

The Spectrum of Thyroid Abnormalities in Individuals with 18q Deletions

Departments of Pediatrics (R.L.S., D.E.H., J.D.C.) and Cellular and Structural Biology (R.J.L.), University of Texas Health Science Center, San Antonio, Texas 78229; and Division of Endocrinology, Cincinnati’s Children’s Hospital Medical Center and University of Cincinnati (S.R.R.), Cincinnati, Ohio 45229

Address all correspondence and requests for reprints to: Dr. Daniel E. Hale, Division of Endocrinology and Diabetes, Department of Pediatrics, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, Texas 78229. E-mail: hale{at}uthscsa.edu.

Chromosome 18q deletions (18q–) are survivable autosomal deletions, having an estimated incidence of one in 40,000 live births. Our long-term goals were to 1) comprehensively define the endocrine phenotype, 2) determine the natural history, and 3) identify key genes leading to particular phenotypes. This report specifically emphasizes the thyroid phenotype. Medical record review and comprehensive clinical assessment(s) were performed on 120 individuals with 18q– at the Chromosome 18 Clinical Research Center, the largest group of individuals with 18q– ever assembled. Affected subjects ranged in age from 6 wk to 32 yr at initial assessment. Due to case reports of thyroid dysfunction in 18q deletions and the well-established association between hypothyroidism and aneusomies, we undertook thyroid testing in all individuals and completed TRH studies on 50 of them. Our studies demonstrated that 12% had hypothyroidism, and the results were consistent with primary thyroidal dysfunction. Furthermore, two individuals progressed from normal to abnormal over the course of 2 yr. Based on these studies, it appears that, as is the case in other aneusomies, annual thyroid testing, using TSH as a primary screening tool, is indicated. The mechanism of the hypothyroidism is not yet known, and the genetic basis has not been delineated.